MT NEWSWIRES
11:27 AM ET 01/04/2023
11:27 AM EST, 01/04/2023 (MT Newswires) -- Checkpoint Therapeutics (CKPT) said Wednesday it has submitted a biologics license application to the US Food and Drug Administration for the approval of cosibelimab to treat patients with metastatic cutaneous squamous cell carcinoma or locally advanced cSCC who are not candidates for curative surgery or radiation.
The application is backed by positive efficacy and safety data from its ongoing trial of cosibelimab, the company said.
Shares of Checkpoint Therapeutics (CKPT) rose more than 6% in recent trading activity.
Recent CKPT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/25/2024 01:01:40 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/24/2024 08:06:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 11:34:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:30:53 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:16:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 12:45:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 01:30:12 AM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/05/2024 10:00:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:15:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 10:15:50 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/30/2024 10:10:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 10:00:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:01:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 12:10:40 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/17/2023 10:02:12 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/17/2023 10:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:15:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 10:10:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 09:00:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:36:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:30:46 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM